Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Plan B Headed For Behind-The-Counter Sale

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA is understood to have decided to approve the emergency contraceptive as a new, third class of product, which would restrict access but not require a prescription.

You may also be interested in...



Plan B Advertising: Barr Has No Plans For Broad DTC Campaign

The company is running ads in college newspapers, but there are no plans for a broader campaign due to uncertainty over whether the emergency contraceptive will be switched over-the-counter.

Plan B Advertising: Barr Has No Plans For Broad DTC Campaign

The company is running ads in college newspapers, but there are no plans for a broader campaign due to uncertainty over whether the emergency contraceptive will be switched over-the-counter.

Crawford FDA Confirmation Vote Expected By Mid-May

The vote would come just over a month after an April 13 Senate Health Committee vote on Crawford's nomination for FDA commissioner was abruptly cancelled. Barr expects FDA approval of its Rx-to-OTC switch application for Plan B once a permanent commissioner is in place.

Related Content

Topics

UsernamePublicRestriction

Register

PS061984

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel